Clinical Trial

Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry

Study acronym: RE-PTT
Recruiting
View on ClinicalTrials.gov →
Summary
REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated. The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-06-13; most recent amendment 2024-05-27.
Status change: Not Yet Recruiting → Recruiting 2024-03-25
Trial Details
NCT Number NCT05914441
Lead Sponsor Fundación Española de Hematología y Hemoterapía
Conditions Purpura, Thrombocytopenic
Enrollment 300 participants
Start Date 2024-03-22
Primary Completion 2026-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-05-29